Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc.
17-2078
Overview
Parties
Amicus Curiae
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA Operating Company
Represented By
3 Attorneys ListedEmail: dkorn@phrma.org
Pharmaceutical Research and Manufacturers of America, 670 Maine Avenue SW
BIOTECHNOLOGY INNOVATION ORGANIZATION NPE (Individual / Inventor)
Represented By
3 Attorneys ListedHansjorg Sauer, Ph.D., Deputy General Counsel
Email: hsauer@bio.org
Biotechnology Innovation Organization, 1201 Maryland Avenue, SW
Email: mbrand@bio.org
Biotechnology Innovation Organization, 1201 Maryland Avenue, SW
Defendant - Appellee
Plaintiff - Appellee
ALKERMES PHARMA IRELAND LIMITED NPE (University / Research)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
Direct: (302) 658-9200, 1201 North Market Street
Plaintiff - Appellant
ACORDA THERAPEUTICS, INC. Operating Company
Represented By
8 Attorneys ListedAnthony Michael, Esq., Attorney
Acorda Therapeutics, Inc.
420 Saw Mill River Road, Ardsley, NY 10502
Stephen J. Elliott, Special Counsel
Sullivan & Cromwell LLP
125 Broad Street, New York, NY 10004-2498
Email: angela@bartlettdefense.com
Federal Defenders of Idaho, 702 W Idaho Street
Defendant - Cross-Appellant
MYLAN PHARMACEUTICALS INC. Operating Company
Represented By
3 Attorneys ListedParker Poe Adams & Bernstein LLP
1180 Peachtree Street, NE, Atlanta, GA 30309
Court & Judges
Court
Court of Appeals for the Federal Circuit (cafc)
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No Co-Pending Disputes Detected in Current Index
There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
(0 total)Docket documents haven't synced yet — they're refreshed once a day. Check back soon, or open the CasLoc app for the live view in the meantime.